Two commercially available progestogen products for cattle, melengestrol acetate (MGA) and norgestomet (SMB), were evaluated for their ability to induce synchronized estrus in anovulatory ewes. Seasonally anestrous ewes ( n = 232) were randomly assigned to one of seven treatments: 1) control ( C ); 2) MGA only (OMGA; .3 mg of MGIVdZ);
Introduction
Lack of commercially available products in the United States specifically approved for use in sheep has inhibited the use of hormonal manipulation techniques for estrus synchronization and improvement of out-of-season breeding practices (Parker and Pope, 1983) . Two products approved for use in beef cattle, melengestrol acetate ( MGA; Upjohn, Kalamazoo, MI) and Syncro-Mate-B (SMB; Sanofi Animal Health, Overland Park, KS), have been used to control reproduction in sheep (Carpenter and Spitzer, 1981; Safranski et al., 1992) . J. h i m . Sci. 1994. 72:3049-3054 A single i.m. injection of PMSG administered at the end of progestogen treatment advances the onset of behavioral estrus, increases ovulation rate, and induces a tighter synchrony of ovulation (Cognie, 1990) . Until recently, sources of PMSG were limited, but now PG-600 (Intervet, Millsboro, DE) , used to induce estrus in prepuberal gilts, provides a commercially available supply of PMSG. Foote (1968) suggested that pretreatment with estrogen might further enhance the induction of estrus and ovulation in anestrous ewes treated with progestogen and PMSG. Zeranol (Ralgro; PitmanMoore, Terre Haute, IN), a commercially available growth promotant for cattle and sheep, has been demonstrated to have effects similar to those of estradiol-17P on serum LH and FSH concentrations in ovariectomized ewes (Elsasser et al., 1983) .
Availability of product, price, method of delivery, and efficacy affect the extent to which progestogens can be used to improve breeding performance in seasonally anestrous ewes. This study was conducted to evaluate further the potential use of MGA and SMB used with and without Ralgro or PG-600 t o induce synchronized estrus in spring-breeding anovular ewes.
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Materials and Methods
Nonlactating, multiparous ewes ( n = 2441, characterized genotypically to consist of approximately 50% Suffolk and varying percentages of Rambouillet, Dorset, and Finnsheep breeding, were bled on April 13 and 17 by jugular venipuncture to determine luteal function via blood serum progesterone analysis. Ewes ( n = 8 ) with blood serum progesterone concentrations of .5 ng/mL or greater were considered cyclic and were not included in the study. The remaining ewes were characterized as being seasonally anovular and were randomly assigned within broad age groups to one of seven treatments (Table 1) 3 mg of norgestomet + an i.m. injection of PG-600 ( 5 mL; PSMB). Thus, this study was designed to include a negative control (Treatment 1) accompanied by a 2 x 3 factorial arrangement of treatments involving two progestogens administered with and without zeranol or PG-600.
More than 90% of the ewes in this study had lambed the previous fall. All ewes were isolated from rams for 2 60 d. Beginning 1 wk before treatment and continuing for 3 wk into the breeding period, ewes were fed whole-shelled corn a t the rate of .45 kg.ewe-l.d-l. Linear feed-trough space was in excess of 25 cdewe. Two weeks before turn-in, a breeding soundness examination ( BSE) , using a point-score system (Ley et al., 1990) , was performed on a pool of ET AL. Suffolk, Dorset, and Hampshire rams. Only rams with BSE classifications of satisfactory or excellent were used for breeding.
Begmning 10 d before breeding, OMGA, RMGA, and PMGA ewes were fed, a t the same time each morning, .45 kg of a 70:30 mixture of whole-shelled corn and a commercially prepared pelleted supplement (2.2 mgkg of MGA). Concomitantly, OSMB, RSMB, and PSMB ewes were given a 3-mg SMB implant (one-half of a cattle implant) inserted S.C. on the back of the ear. Immediately preceding initiation of the MGA and SMB treatments, RMGA and RSMB ewes were given a single i.m. injection of 2.5 mg of zeranol. To prepare zeranol suspensions, Ralgro pellets were transferred to injection vials, and ethanol (10% of the final volume) was added to the vials, which were allowed to stand until the pellets dispersed. As the final step, an appropriate amount of corn oil was added to the vials to provide a 2.5-mg dose of zeranol delivered in a 2-mL injection.
At the end of the 10-d treatment period, MGA feeding was discontinued and the SMB implants were removed through a small incision made in the skin at the distal end of the implant. Concomitantly, PMGA and PSMB ewes were given a single i.m. injection of PG-600 ( 5 mL). Ewes in all treatment groups were combined into one breeding group on May 4, 1992, with a ram:ewe ratio of 1:17 for a 30-d breeding period. All rams were equipped with marking harnesses. Marker colors were changed on d 10 and 20 of the breeding period. Ewes were checked daily at 0900, and marking information was recorded. To monitor luteal activity, blood samples for serum progesterone analysis were collected by jugular venipuncture from C ewes 11 and 4 d before ram introduction, and from C, OMGA, and OSMB ewes a t 4, 7, 9, and 14 d after ram introduction. After collection, blood samples were stored out of direct sunlight and allowed to clot. Serum samples were collected and frozen until all samples could be assayed for progesterone concentration.
Concentrations of progesterone were determined in 100 pL of serum, in duplicate, with the Coat-A-Count Chi-square analyses were conducted using the frequency procedures in SAS (1990) to determine the effect of treatment on the categorical variables mating, luteal activity, fertility, and prolificacy. Analysis of variance was conducted, using the GLM procedures in SAS, to evaluate the fixed effect of treatment on lambing interval. Orthogonal contrasts for control vs treated ewes, and the factorial effects of progestogen, injection of zeranol or PG-600, and their interactions were tested for all dependent variables using the CATMOD and GLM procedures in SAS.
Results and Discussion
Estrus and Luteal Activity. A greater ( P < ,001)
proportion of progestogen-treated ewes mated a t synchronized estrus (Table 2) . Rams marked more ( P < .001) SMB ewes during the first 5 d of breeding than MGA ewes. Within MGA treatments, RMGA ewes tended ( P < .08) to have a more synchronized estrus than OMGA or PMGA ewes. Except for the C and PMGA treatments, repeat matings after the synchronized estrus exceeded 20%. Overall, there were no treatment differences in estrus response for the 30-d breeding period.
Progestogen priming of seasonally anovular ewes, previously isolated from rams, dramatically increases estrus response upon ram exposure (Oldham and Fisher, 1992) . Cognie et al. (1982) treated anovular Merino ewes for 12 d with intravaginal sponges impregnated with 30 mg of flurogestone acetate (FGA) before ram exposure. Response to synchronized estrus was 97% for FGA-treated ewes, compared with 20% for nontreated control ewes. Ewe response to synchronized estrus obtained by Hunter et al. (1971) using a 14-d priming of anovular ewes with FGA intravaginal sponges were similar to those in our study, with repeat matings after synchronized estrus of 25 and 16.296, respectively, for their 2-yr study. Safranski et al. (1992) reported a 55 and 70% response to synchronized estrus in seasonally anestrous ewes treated for 9 d with MGA or MGA/PG-600, respectively, compared with 9% for nontreated control ewes, Five groups of anestrous ewes treated a t different times from February through June with a 3-mg norgestomet implant for 10 d followed by a n injection of 750 IU of PMSG at implant removal had a n average response to synchronized estrus of 72% compared with 10% for nontreated control ewes 
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JABBAR ET (Carpenter and Spitzer, 1981) . Neither of these estrous periods.
studies monitored repeat matings at subsequent All blood serum samples obtained from C ewes a t 11 and 4 d before breeding contained less than .5 ng/mL of progesterone. Blood serum samples obtained from C, OMGA, and OSMB ewes during the first 14 d of breeding were used as an indicator of corpus luteum ( CL) formation. Progesterone concentrations greater than .5 ng/mL were found in 96, 100, and 93% of OMGA, OSMB, and C ewes, respectively (Table 2) . Even though a large proportion of C ewes had luteal
MGA/PG-600 treated ewes, respectively, ovulated z within 12 d, and only 9% of control ewes mated within a that period, compared with 70% of the MGA/PG-600
anovular ewes, after an appropriate period of isolation 5 from rams, causes spontaneous ovulation within 50 h activity, the rams marked only 12% of them within the first 17 d of breeding. Similar results were obtained by Safranski et al. (1992) ; 83 and 99% of control and c .* 3 treated ewes. Acute introduction of rams to seasonally after ram exposure; this phenomenon is called the "ram effect'' (Martin et al., 1986) . Typically, this ovulatory response is not accompanied by estrus and (approximately 50%) within 6 d after ram introducwith normal life spans (Oldham and Martin, 1979) . estrus, thus giving two peaks of breeding activity at 18 and 24 d after ram introduction (Signoret, 1990) . Lambing. Progestogen-treated ewes had a shorter ( P < .003) mean interval from ram introduction to lambing ( Table 3) . Within progestogen treatments, from ram introduction to lambing than did RMGA, OSMB, RSMB, and PSMB ewes. Fertility for MGA, SMB, and C ewes was not different. However, within SMB treatments, only 59% of OSMB ewes lambed compared ( P < .05) with 90% of RSMB and PSMB ewes. Poor synchronization of ovulation may have occurred in OSMB ewes due to the lack of PMSG at the end of progestogen treatment induced a tighter synchrony of ovulation. Gordon ( 19 7 5 ) reported that many spring-mated ewes treated with progestogen/PMSG return to anestrus upon failure to conceive a t first estrus. Of the OSMB ewes not conceiving at synchronized estrus, only 5 of 8 were remarked in the second period compared with 9 of 10 and 7 of 9 of the RSMB and PSMB ewes, respectively.
A greater proportion of progestogen-treated ewes lambed within the first 10 d of the lambing period as a result of more fertile matings at synchronized estrus (Figure 1 1. There was no difference in prolificacy due t o treatment. Ewes primed with a single injection of zeranol before MGA or SMB treatment had fertility and intervals from ram introduction to lambing similar to those of ewes receiving an injection of PG-600 after progestogen treatment. Foote ( 1968) reported that the incidence of estrus and ovulation and the subsequent proportion of pregnant ewes was consistently greater in anestrous ewes receiving estrogen before progestogedPMSG treatment. Beck and Reeves ( 1973) reported peak LH concentrations similar to those in preovulatory serum from cyclic ewes when anestrous ewes were given a single i.m. injection of 2 12.5 pg of estradiol-17P. Because the cost was less than 10% of PG-600, zeranol may provide a more economical means of assuring adequate fertility when progestogen treatments are used. More work should be done to determine the physiological responses to zeranol in anovular ewes, especially at the level of the ovary. Zeranol has estrogenic activity (Peck and Chesworth, 1977) and elicits an increase in LH release after a single injection in ovariectomized ewes (Elsasser et al., 1983) . Furthermore, zeranol stimulates estrus at the end of progestogen treatment (Burke and Keisler, 1988; Lewis and Goebel, 1993) .
Results from this study are in general agreement with those reported for other studies for anovular ewes treated with MGA (Keisler, 1992; Safranski et al., 1992; Umberger and Lewis, 1992) or SMB (Carpenter and Spitzer, 1981; Alifakiotis et al., 1982; Tritschler et al., 199 1) . In general, out-of-season lambing response tended to be greater for all treatments than those reported previously. This may have occurred because the population of ewes in this study had a history of fall lambing. Wheaton et al. (1992) reported similar levels of fertility and prolificacy for progesteronetreated ewes and untreated control ewes exposed for breeding in May and June. They suggested that in addition to the ram effect, the improved reproductive performance of the control ewes may have occurred as a result of commingling with progesterone-treated ewes in the same breeding group. After ram introduction, progesterone-treated ewes exhibited an earlier estrus, which may have stimulated estrus in the control ewes. Nugent and Notter (1990) showed a 16% increase in mating activity of acyclic ewes exposed to vasectomized rams in the presence of cyclic ewes compared with acyclic ewes exposed to vasectomized rams only. The reproductive performance of C ewes in this study may have benefited from the cohabitation of C and progestogen-treated ewes in the same breeding group. However, unless a concentrated lambing period is a priority, these results indicate that the ram effect may be as effective as progestogen treatment for out-of-season breeding.
To our knowledge, this is the only study in which direct comparisons have been made between MGA and SMB. Greater fertility for OMGA than for OSMB ewes merits further evaluation. Other studies indicated that gonadotropin treatment (Safranski et al., 1992) or treatment with estrogen-like compounds (Umberger and Lewis, 1992) at the end of MGA treatment was not beneficial, but similar studies with SMB have not been reported.
Implications
Results from this study of the occurrence of estrus, luteal activity, and lambing are similar to generally accepted arguments presented in other studies for the response of progestogen-treated anovulatory ewes to natural mating. Syncro-Mate-B and melengestrol acetate used in combination with zeranol or PG-600 are effective in shortening the interval from ram introduction to lambing. Priming with zeranol before progestogen treatment is as effective and more economical than gonadotropin treatment at progestogen removal.
